Niagen Bioscience Inc (NAGE)

EBITDA

$18.32M

TTM · Period ending: · USD

NAGE logo

NAGE EBITDA

Latest reported$18.32M
NAGE TTM EBITDA (-$23.31K → $18.32M)
High-resolution chart · PNG

NAGE ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Niagen Bioscience Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
18,320,000
21,242,000
19,642,000
22,692,000
19,777,000
16,040,000
10,339,000
2,984,000
229,000
-1,873,000
-3,233,000
-6,794,000
-6,814,000
-11,023,000
-16,744,000
-18,598,000
-26,492,000
-25,675,000
-25,447,000
-26,205,000
-21,599,000
-19,774,000
-18,341,000
-21,158,000
-23,825,000
-27,299,000
-29,777,000
-29,283,000
-31,165,000
-32,110,000
-32,330,000
-32,926,647
-27,544,647
-22,260,647
-15,660,647
-9,056,629
-6,895,052
-3,970,953
-1,802,276
-951,919
134,780
-442,940
-1,819,957
-1,699,797
-2,545,284
-4,019,793
-4,971,026
-4,589,208
-5,188,051
-4,562,928
-4,115,488
-5,070,208
-5,334,366
-8,284,020
-11,286,663
-12,070,453
-12,921,787
-10,752,517
-7,465,358
-5,867,584
-4,344,261
-2,809,201
-1,629,741
-852,443
-154,783
-145,080
-498,231
-1,012,788
-1,539,614
-1,977,938
-1,759,558
-1,235,814
-636,727
-13,685
-23,307
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.